In this issue:
MOGAD proposed diagnostic criteria
Anti-CD20 therapy for MS-associated uveitis
Long-term outcomes following COVID-19 in MS
sNfL & cognition changes in secondary progressive MS
Size & shape of CVS lesions for MS diagnosis
Neutropenia in MS treated with anti-CD20
Periventricular remyelination failure in MS & neurodegeneration
A new framework for MS progression
Patterns of immune cell dynamics with cladribine
Pregnancy outcomes after DMD exposure in MS
Please login below to download this issue (PDF)